Oncternal Therapeutics's total assets for Q3 2024 were $15.60M, a decrease of -34.61% from the previous quarter. ONCT total liabilities were $6.45M for the fiscal quarter, a -20.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.